Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.

Background: The progress of antiretroviral treatment roll-out programs in developing countries requires extensive monitoring of primary drug resistance prior to initiation of therapy. This is particularly relevant for Cameroon where a high HIV diversity has been reported.

Objectives: To determine HIV diversity in Yaoundé, Cameroon, in a cohort of HIV-infected subjects with advanced disease.